Profluent的动态

Patrick Bet-David explains why the FDA has officially approved CRISPR gene editing as a treatment for Sickle Cell Disease, marking a historic milestone in medical science. The science behind CRISPR-Cas9, a revolutionary gene-editing tool has transformed biomedical research. Understand how it can precisely alter DNA to correct genetic defects, potentially treating a range of illnesses. As CRISPR technology advances, so does the debate over its ethical use. PBD also discusses the controversial topic of designer babies, examining the moral implications and potential societal impacts of gene editing for non-therapeutic purposes. Connect one-on-one with the right expert to get the answers you need with Minnect: https://bit.ly/3MC9IXE Get best-in-class business advice with Bet-David Consulting: https://bit.ly/40oUafz Visit VT.com for the latest news and insights from the world of politics, business and entertainment: https://bit.ly/472R3Mz Visit Valuetainment University for the best courses online for entrepreneurs: https://bit.ly/47gKVA0

?? Harnessing the Power of Biotechnology for Better Health ?? Hi everyone! I recently came across a fascinating video that perfectly captures why I’m so passionate about biotechnology and its potential to revolutionize healthcare. https://lnkd.in/gCcDXWtd In this video, you’ll see how cutting-edge biotechnological advancements are transforming the way we diagnose, treat, and even prevent diseases. From gene therapy to personalized medicine, the possibilities are truly endless. ?? Key Takeaways: Gene Editing: How CRISPR technology is paving the way for new treatments. Personalized Medicine: Tailoring healthcare solutions to individual genetic profiles. Sustainability in Healthcare: Biotech innovations contributing to eco-friendly practices. As a Biotechnologist and Phlebotomist, I’m excited to be part of this rapidly evolving field, where every day brings new opportunities to improve patient outcomes and push the boundaries of what’s possible in medicine. I’d love to hear your thoughts on this! How do you see biotechnology shaping the future of healthcare? Let’s connect and keep the conversation going. ?? #Biotechnology #HealthcareInnovation #GeneEditing #PersonalizedMedicine #SustainableHealthcare #CareerInScience

Characterizing collections of molecules is an important chemoinformatics task. Beyond annotating molecules by common descriptors, can we gain insight by leveraging LLMs for initial triage? Our prototype app, MolSifter, does just that! We've been using NVIDIA Healthcare MolMIM model — guided by our own perturbation predictions — to generate molecules with specific effects on gene expression. LLMs help by 1) orienting us to interesting patterns in a collection and 2) enabling chat-based analysis to gain deeper insight. We are continuously exploring and building tools like MolSifter to map the relationships between chemical structure and gene expression to discover powerful new therapies for patients.

Ubiquitous Innovation Doesn't Exist The term "innovation" is often thrown around too casually, diluting its true meaning. In a world where everything is labeled as innovative and groundbreaking, it becomes easy to overlook the genuinely pioneering advancements. Over the past few weeks, I've come across three remarkable papers that build upon the groundbreaking discoveries of CRISPR and CAR-T, propelling us into awe-inspiring territories. Let's take a moment to appreciate the remarkable progress and the society that emerges from the freedom and transparency of research. Check out these thought-provoking articles: 1. Gene Editing Gives Hope for Inherited Blindness: (https://lnkd.in/gKgXeXS9) 2. Gene Therapy Transforming Inherited Deafness: (https://lnkd.in/g92dvhxr) 3. The Promise of CAR-T Cells : Application to Severe Asthma (https://lnkd.in/gsNQ_dPQ) Let's continue to champion true innovation, transformational medicine, and scientific leadership. #Innovation #TransformationalMedicine #ScienceLeadership ??

AI in Precision Medicine and Gene Editing: Transforming Healthcare #PrecisionMedicine #GeneEditing #AIHealthcare Experience the future of healthcare transformation with AI at the helm of precision medicine and gene editing—companies like Profluent and Caribou Biosciences harness artificial intelligence's power to revolutionize therapeutic development. From achieving unprecedented precision in genetic edits to predicting treatment outcomes with accuracy, AI is driving groundbreaking innovations that promise to enhance patient care and outcomes. Don't miss out on this exciting journey toward personalized medicine and the potential for transformative breakthroughs in healthcare. Let's dive into the basics of how it is done. Join the conversation now! #HealthTech #Innovation #AIAdvancements #FutureOfMedicine

Thanks, SAP AG, for the solutions to support healthcare and Cell and Gene Therapy Orchestration, of course we can do much more and superb best for healthcare services and let's apply the greatness of " Quantum Computing's and Quantum Applications to Mankind". Thanks God, for your support and blessings, as I could complete the training and Record of Achievement on "SAP Cell and Gene Therapy Orchestration."

Is molecular medicine on the cusp of a revolution? Can we truly modulate gene expression with precision to treat diseases that were once considered untreatable? The answer, excitingly, lies in Antisense oligonucleotides or ASOs. These are customized snippets of DNA or RNA that bind to messenger RNA, effectively silencing genes by blocking protein production. They act as precise molecular tools to modulate gene expression. Narrated by Luke McLaughlin, Biotech Digital Marketer, Business Developer and Life Science Content Creator https://lnkd.in/dBTweiZQ

DCAT (Drug, Chemical & Associated Technologies Association) Week 2024 may have just wrapped up, but SK pharmteco was there in force! One example was Jeet Sarkar, our global head of IT, discussing the exciting role of AI in revolutionizing cell and gene therapy supply chains! ? Jeet showcased real-world examples of how SK pharmteco is leveraging AI and machine learning (ML) to streamline processes and minimize errors. As a leading manufacturer of cell and gene therapy technologies, APIs, and intermediates, this is crucial for us. ? The discussion highlighted AI's potential to improve efficiency, reduce risks, and propel the industry forward. While challenges exist, education is key to overcoming them. ? At SK pharmteco, we're committed to staying ahead of the curve.?Our focus on AI adoption positions us as a leader in optimizing cell and gene therapy supply chains. https://lnkd.in/gYDrnmXN ? #DCATWeek #AI #cellandgenetherapy #supplychain #innovation #SKpharmteco

"The majority of cell and gene therapies are discovered and developed in academic settings characterized by complex and highly manual processes. With highly skilled scientists physically implementing each step, these processes aren’t scalable at a commercial level." We can't wait for more companies and organizations to adopt technologies like Krakatoa?, our benchtop media maker, that completely automate critical upstream processes. 2024 also promises much in the development of AI, which we can only see further contributing to decentralized manufacturing and eliminating human error. #decentralizedmanufacturing #celltherapy #bioprocessing https://hubs.ly/Q02f2Hy60